Laryngeal Sensory Dysfunction and Aspiration Risk: Mechanisms, Clinical Implications, and Management Strategies

Abstract

Laryngeal sensory dysfunction (LSD) is increasingly recognized as a pivotal factor underlying aspiration and its sequelae, particularly in vulnerable populations. This review synthesizes current evidence on the epidemiology, pathophysiology, clinical characteristics, diagnostic modalities, and management of LSD with respect to aspiration risk. Emphasis is placed on recent advances in diagnostic and therapeutic approaches, alongside contemporary guideline recommendations, to provide a comprehensive resource for clinicians managing patients at risk for aspiration due to compromised laryngeal sensation.

Introduction

Aspiration, the misdirection of oropharyngeal or gastric contents into the lower respiratory tract, remains a significant cause of morbidity and mortality worldwide, particularly among the elderly and those with neurological or structural disorders. Laryngeal sensory dysfunction has emerged as a critical contributor to impaired airway protection, yet remains underdiagnosed and frequently overlooked in clinical practice. Understanding the mechanisms by which LSD heightens aspiration risk is essential for the development of effective preventive and therapeutic strategies. This review aims to elucidate the complex interplay between laryngeal sensory integrity and airway protection, providing clinicians with an evidence-based framework for evaluation and management.

Epidemiology / Disease Burden

The prevalence of laryngeal sensory dysfunction varies widely depending on the population studied and the diagnostic criteria employed. In post-stroke cohorts, up to 40% may exhibit evidence of impaired laryngeal sensation, correlating with increased rates of aspiration pneumonia. Among patients with Parkinson’s disease and other neurodegenerative disorders, rates are similarly high, with dysphagia and silent aspiration contributing substantially to morbidity. Elderly individuals, particularly those in long-term care, are at elevated risk due to age-related sensory decline and comorbidities. LSD-related aspiration is a leading contributor to hospital admissions, prolonged length of stay, and healthcare costs, underscoring its clinical and public health significance.

Pathophysiology

Laryngeal sensation is mediated primarily by the internal branch of the superior laryngeal nerve, a branch of the vagus nerve, which supplies afferent input from the supraglottic and glottic regions. Sensory feedback from the larynx is integral to triggering protective reflexes, including the laryngeal adductor reflex (LAR), which rapidly closes the vocal folds in response to penetration by foreign material. Disruption of this afferent pathway whether from nerve injury, neurodegeneration, or local inflammation attenuates reflexive airway closure, permitting silent aspiration. Central processing deficits, as observed in stroke or dementia, further compound the risk by impairing the integration and execution of reflexive responses.

Risk Factors

Multiple factors predispose individuals to LSD and subsequent aspiration. Neurological disorders such as stroke, Parkinson’s disease, multiple sclerosis, and amyotrophic lateral sclerosis are well-established contributors. Surgical interventions involving the neck, particularly thyroidectomy and carotid endarterectomy, may inadvertently damage laryngeal sensory nerves. Prolonged endotracheal intubation and tracheostomy are also implicated due to mechanical trauma and desensitization. Additional risk factors include head and neck radiation, chronic gastroesophageal reflux, advanced age, diabetes mellitus (due to peripheral neuropathy), and recurrent laryngeal infections.

Clinical Features

LSD often manifests insidiously, with classic symptoms including reduced cough or throat clearing in response to food or secretions, recurrent pneumonia, unexplained weight loss, and persistent dysphonia. Notably, many patients experience "silent aspiration" the passage of material below the vocal folds without eliciting cough complicating clinical detection. Subtle signs such as weak or ineffective cough, gurgly voice quality after swallowing, or unexplained low-grade fevers may provide indirect evidence of impaired laryngeal sensation. In high-risk groups, vigilant clinical assessment is warranted even in the absence of overt symptoms.

Diagnosis

Diagnosis of LSD and aspiration risk relies on a combination of clinical evaluation and specialized testing. Bedside swallowing assessments, while useful, are limited in sensitivity for silent aspiration. Instrumental diagnostics such as fiberoptic endoscopic evaluation of swallowing with sensory testing (FEESST) enable direct visualization of laryngeal responses to calibrated air pulses, quantifying sensory thresholds. Videofluoroscopic swallow studies (VFSS) provide dynamic assessment of bolus transit and airway protection, though they do not directly measure sensory function. Emerging modalities include high-resolution pharyngeal manometry and neurophysiological assessments. Standardized protocols and multidisciplinary collaboration enhance diagnostic accuracy.

Treatment & Management

Management of LSD centers on mitigating aspiration risk and optimizing airway protection. Swallowing rehabilitation, including sensory stimulation techniques (e.g., thermal-tactile stimulation, sour bolus trials), can enhance laryngeal responsiveness. Compensatory maneuvers such as supraglottic swallow and effortful swallow strategies are frequently employed. In selected cases, neuromodulatory interventions such as pharyngeal electrical stimulation have demonstrated benefit in augmenting sensory input. Pharmacologic therapies, including capsaicin and TRPV1 agonists, are under investigation for their potential to enhance laryngeal sensitivity. Nutritional support, ranging from modified diets to enteral feeding, may be necessary in severe cases to prevent recurrent aspiration and malnutrition.

Recent Advances / Emerging Therapies

Recent research has focused on refining diagnostic techniques and developing targeted therapies for LSD. Advances in FEESST technology have improved reproducibility and patient tolerance. Neuromodulation, including repetitive transcranial magnetic stimulation and transcutaneous electrical stimulation, shows promise in restoring laryngeal sensory and motor function. Early-phase studies of pharmacologic agents targeting sensory pathways are ongoing, with preliminary data suggesting potential benefit. Moreover, machine learning algorithms are being developed to enhance risk stratification and personalize intervention strategies. Ongoing clinical trials will further clarify the role of these emerging therapies in routine practice.

Guideline Recommendations

Contemporary guidelines from organizations such as the American Speech-Language-Hearing Association (ASHA) and the European Society for Swallowing Disorders emphasize early identification of at-risk individuals, prompt referral for instrumental assessment, and multidisciplinary management. Routine screening for laryngeal sensory deficits is advocated in high-risk populations, particularly post-stroke and post-extubation patients. Individualized care plans incorporating behavioral, dietary, and, where appropriate, neuromodulatory interventions are recommended. Ongoing education of clinicians and caregivers is essential to optimize outcomes and reduce the burden of aspiration-related complications.

Conclusion

Laryngeal sensory dysfunction constitutes a significant, yet often underappreciated, risk factor for aspiration and its attendant complications. Advances in diagnostic technology and emerging therapeutic modalities offer new avenues for risk stratification and intervention. Early recognition, comprehensive assessment, and a multidisciplinary, individualized management approach are paramount in reducing aspiration risk and improving patient outcomes. Continued research and guideline development will be critical in addressing the challenges posed by LSD in diverse clinical settings.